HCA
FLGT icon

Harbor Capital Advisors’s Fulgent Genetics FLGT Stock Holding History

Harbor Capital Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-416
Closed -$8K – 1456
2024
Q4 		$8K Buy
416
+66
+19% +$1.29K ﹤0.01% 1025
2024
Q3 		$8K Buy
+350
New +$7.83K ﹤0.01% 1032

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Harbor Capital Advisors's FLGT Position: Q1 2025 in Review

Harbor Capital Advisors sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 416 shares — an estimated $8K sold.

Harbor Capital Advisors first reported a position in FLGT in Q3 2024 and held it in 2 quarters. The position peaked at $8K in Q4 2024. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Harbor Capital Advisors reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Harbor Capital Advisors sold 416 Fulgent Genetics shares in Q1 2025, an estimated $8K.
  • Harbor Capital Advisors first reported a position in Fulgent Genetics in Q3 2024 and held it in 2 quarters.
  • Harbor Capital Advisors's Fulgent Genetics position peaked at $8K in Q4 2024.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Harbor Capital Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.